| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 10/04/2011 | USRE42802 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 10/04/2011 | US8030518 E.g., N-(5-(4-fluorophenylamino)-1,3-dimethyl-5,6,7,8-tetrahydronaphthalen-2-yl)-3,3-dimethylbutanamide; treating or preventing neuropathic and chronic pain, bipolar disorder, migraine, epilepsy, a seizure or a disorder characterized by a seizure |
| 10/04/2011 | US8030517 CCR9 inhibitors and methods of use thereof |
| 10/04/2011 | US8030506 Tumor selective and biodegradable cyclotriphosphazene-platinum(II) conjugate anticancer agent, and preparation method thereof |
| 10/04/2011 | US8030499 1,3-dihydro-2H-indole-2-one compound and pyrrolidine-2-one compound fused with aromatic heterocycle |
| 10/04/2011 | US8030498 Benzoylpyrazole compounds and herbicides containing them |
| 10/04/2011 | US8030495 Cyclopropyl pyrrolidine orexin receptor antagonists |
| 10/04/2011 | US8030492 Compositions to effect neuronal growth |
| 10/04/2011 | US8030488 Piperazine derivatives as stearoyl-coa desaturase inhibitors and their use as therapeutic agents |
| 10/04/2011 | US8030487 2-amino—5-substituted pyrimidine inhibitors |
| 10/04/2011 | US8030484 Substituted triazines as prion protein ligands and their use to detect or remove prions |
| 10/04/2011 | US8030462 Immunotherapy; induce immunology response |
| 10/04/2011 | US8030459 Oxime conjugates and methods for their formation and use |
| 10/04/2011 | US8030362 Admixing a pharmaceutical agent with a foam forming agent; introducing the mixture of into a dispensing device; metered dose, external auditory meatus |
| 10/04/2011 | US8030360 Anti-wrinkle agent |
| 10/04/2011 | US8030359 Polymer formulations of CETP inhibitors |
| 10/04/2011 | US8030358 Methods and pharmaceutical compositions for decorporation of radioactive compounds |
| 10/04/2011 | US8030357 Use of bupropion metabolites for the treatment of inflammatory disorders |
| 10/04/2011 | US8030356 N-hydroxylsulfonamide derivatives as new physiologically useful nitroxyl donors |
| 10/04/2011 | US8030355 Tablet composition with a prolonged release of tamsulosin |
| 10/04/2011 | US8030354 Substituted biphenyl GPR40 modulators |
| 10/04/2011 | US8030353 Preparation of the formaurindicarboxylic acid base and its derivations and use |
| 10/04/2011 | US8030352 Method of producing retinyl esters |
| 10/04/2011 | US8030351 Treatment of animal carcasses |
| 10/04/2011 | US8030349 Method for prevention of degradation of thermally unstable medicament |
| 10/04/2011 | US8030348 Natural marine source phospholipids comprising polyunsaturated fatty acids and their applications |
| 10/04/2011 | US8030347 Cylopenta[b]benzofuran derivatives and the utilization thereof |
| 10/04/2011 | US8030346 Heterocyclic quinolone derivatives that inhibit prolyl hydroxylase activity |
| 10/04/2011 | US8030345 Tricyclic pyrazole derivatives as cannabinoid receptor modulators |
| 10/04/2011 | US8030344 Such as (S)-2-(Dimethylamino)ethyl-1-(4-(2-aminophenylcarbamoyl)-phenyl)pyrrolidin-3-ylcarbamate for treating cell proliferative disorders |
| 10/04/2011 | US8030343 Phosphodiesterase inhibitor; tumor necrosis factor antagonist; autoimmune diseases; sepsis; malaria ; skin disorders; anticancer agents; antiarthritic agents; Crohn's disease; inflammatory bowel disorders |
| 10/04/2011 | US8030342 Dendritic polyamidoamine phthalocyanine derivative |
| 10/04/2011 | US8030341 Dual delta and mu opioid receptor antagonist; 3,6-Bis(Boc-Dmt-Tic-NH-methyl)-2(1H)-pyrazinone |
| 10/04/2011 | US8030339 Imidazole derivatives for the treatment of anxiety and related diseases |
| 10/04/2011 | US8030338 Method for producing 2-nitroimidazole derivative |
| 10/04/2011 | US8030337 Tricyclic compound and pharmaceutical use thereof |
| 10/04/2011 | US8030336 Nicotinamide-based kinase inhibitors |
| 10/04/2011 | US8030335 Use of liver X receptor agonists |
| 10/04/2011 | US8030334 Organic compounds |
| 10/04/2011 | US8030333 Benzimidazole compound crystal |
| 10/04/2011 | US8030332 Potassium channel inhibitors |
| 10/04/2011 | US8030331 Allosteric modulators of metabotropic glutamate receptors |
| 10/04/2011 | US8030330 Benzothiophenes, formulations containing same, and methods |
| 10/04/2011 | US8030329 N-biarylamides |
| 10/04/2011 | US8030328 Imidazolone phenylalanine derivatives |
| 10/04/2011 | US8030327 Fused imidazole derivative |
| 10/04/2011 | US8030326 Crystalline forms of rapamycin analogs |
| 10/04/2011 | US8030325 Biosynthetic gene cluster for the production of a complex polyketide |
| 10/04/2011 | US8030324 Pyridine derivatives for the treatment of metabolic disorders related to insulin resistance or hyperglycemia |
| 10/04/2011 | US8030323 Pyrazole carboxamide derivatives, pharmaceutical compositions and its preparation |
| 10/04/2011 | US8030322 Spirocompounds useful as modulators for dopamine D3 receptors |
| 10/04/2011 | US8030321 Benzofuro- and benzothienopyrimidine modulators of the histamine H4 receptor |
| 10/04/2011 | US8030320 Derivatives of 1-OXO-1,2-dihydroisoquinoline-5-carboxamides and of 4-OXO-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 10/04/2011 | US8030319 Methods for treating cancer and other pathological proliferating disorders by inhibiting mitosis using pyrrolo[2 3-d]pyrimidines |
| 10/04/2011 | US8030318 Fused bicyclic inhibitors of HCV |
| 10/04/2011 | US8030317 MAPK/ERK kinase inhibitors |
| 10/04/2011 | US8030316 Malate salt of (2R)-methyl-1-{3-[2-(3-pyridinyloxy)ethoxy]-2-pyrazinyl}piperazine |
| 10/04/2011 | US8030315 DPP-IV inhibitor including beta-amino group, preparation method thereof and pharmaceutical composition containing the same for preventing and treating diabetes or obesity |
| 10/04/2011 | US8030314 for the treatment of extrapyramidal movement disorders |
| 10/04/2011 | US8030313 Controlled release sterile injectable aripiprazole formulation and method |
| 10/04/2011 | US8030312 Administering therapeutically effective amount of a carbostyril derivative compound for therapy of nervous system disorders |
| 10/04/2011 | US8030311 Phenylacetamides suitable as protein kinase inhibitors |
| 10/04/2011 | US8030310 Therapeutic agents useful for treating pain |
| 10/04/2011 | US8030309 Viral polymerase inhibitors |
| 10/04/2011 | US8030308 Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors |
| 10/04/2011 | US8030306 Azabicyclic heterocycles as cannabinoid receptor modulators |
| 10/04/2011 | US8030305 Triazolopyridazines as kinase modulators |
| 10/04/2011 | US8030304 Thiazole pyrazolopyrimidines CRF1 receptor antagonists |
| 10/04/2011 | US8030303 Salt of morpholine compound |
| 10/04/2011 | US8030302 Amidophenoxyindazoles useful as inhibitors of c-Met |
| 10/04/2011 | US8030301 Treatment of cancers with methylol-containing compounds and at least one electrolyte |
| 10/04/2011 | US8030300 2-pyrrolidinyloxy-substituted pyridine; Alzheimer's disease, Parkinson's disease, dyskinesias, Tourette's syndrome, schizophrenia, attention deficit disorder, anxiety, pain, depression, obsessive compulsive disorder |
| 10/04/2011 | US8030299 Palladium complexes inhibit N-myristoyltransferase activity in vitro and cancer growth in vivo |
| 10/04/2011 | US8030298 17β-HSD1 and STS inhibitors |
| 10/04/2011 | US8030297 Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders |
| 10/04/2011 | US8030296 Oestrogen-17-sulphamates as inhibitors of steroid sulphatase |
| 10/04/2011 | US8030295 19,26,27-trinor-1α,25-dihydroxyvitamin D3 compounds |
| 10/04/2011 | US8030294 Cytosine-containing or cytidine-containing compound, creatine-containing compound, adenosine-containing, or adenosine-elevating compound |
| 10/04/2011 | US8030293 Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders |
| 10/04/2011 | US8030292 Antisense antiviral compounds and methods for treating a filovirus infection |
| 10/04/2011 | US8030291 Antisense antiviral compounds and methods for treating a filovirus infection |
| 10/04/2011 | US8030290 Cell-type specific aptamer-siRNA delivery system for HIV-1 Therapy |
| 10/04/2011 | US8030289 Oligonucleotide and use thereof |
| 10/04/2011 | US8030288 Methods for identifying compounds for the treatment of type 1 diabetes |
| 10/04/2011 | US8030286 decreasing elongation factor 2 (eEF2) kinase activity in cell by reducing expression of a gene encoding the eEF2 kinase; hypoxia, anoxia, ischemia, stroke, and neurogenerative diseases; polynucleotide biodrugs; regulating protein turnover, protect cell due to stress, exposure to chemotherapy, radiation |
| 10/04/2011 | US8030285 Asthma; ellergy vaccine; antisense therapy; used to treat, prevent, or ameliorate the symptoms resulting from exposure to a bio-warfare agent |
| 10/04/2011 | US8030283 Stabilization of amrubicin hydrochloride |
| 10/04/2011 | US8030282 Motilide polymorphs |
| 10/04/2011 | US8030067 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof |
| 10/04/2011 | US8029833 Herbal composition for treating CD33+ acute and chronic myeloid leukemia and a method thereof |
| 10/04/2011 | US8029832 Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 10/04/2011 | US8029830 Composition and method for promoting internal health and external appearance |
| 10/04/2011 | US8029823 Controlled release and taste masking oral pharmaceutical composition |
| 10/04/2011 | US8029820 Patches containing tulobuterol |
| 10/04/2011 | US8029819 Pet food includes 35-70% by weight protein, 4-10% by weight fat, 5-25% by weight fiber, 10-35% by weight digestible carbohydrate, 0.1-1% by weight functional ingredient to build lean muscle mass |
| 10/04/2011 | US8029818 Reducing postprandial glycemic excursion to carbohydrates by feeding supplemental fructose prior to carbohydrate challenge |
| 10/04/2011 | US8029815 Methods for treating or preventing restenosis and other vascular proliferative disorders |
| 10/04/2011 | US8029812 Personal care compositions |
| 10/04/2011 | US8029811 Stabilized pharmaceutical product |
| 10/04/2011 | US8029810 Water-based delivery systems |